Exploring potential targets for natural product therapy of DN: the role of SUMOylation
Diabetic nephropathy (DN) is a common and serious micro-vascular complication of diabetes and a leading cause of end-stage renal disease globally. This disease primarily affects middle-aged and elderly individuals, especially those with a diabetes history of over 10 years and poor long-term blood gl...
Saved in:
Main Authors: | Jingjing Wang (Author), Rui Zhang (Author), Chenguang Wu (Author), Lifan Wang (Author), Peng Liu (Author), Ping Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Products Against Renal Fibrosis via Modulation of SUMOylation
by: Peng Liu, et al.
Published: (2022) -
The emerging roles of SUMOylation in pulmonary diseases
by: Xuyang Zheng, et al.
Published: (2023) -
Targeting STAT SUMOylation to enhance NK cell cytotoxicity
by: A. Macedo, et al.
Published: (2019) -
New insights into SUMOylation and NEDDylation in fibrosis
by: Jin Han, et al.
Published: (2024) -
Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy
by: Chenguang Wu, et al.
Published: (2023)